Is your sampling program driving accessibility and prescriptions or are your samples sitting in a cabinet?

Discover what has changed since 2005.

__________________________________________________________________

Samples are likely one of your major marketing investments and represent one of the top 3 reasons physicians grant visits to pharmaceutical representatives.*

You’re interested in sourcing answers to key questions…

• Are samples in your therapeutic category important and how do they influence drug choice?
• What new delivery methodologies are appealing to today’s busy physician?
• Are you optimizing your program in terms of providing enough samples to aid the GP/FP in assessing efficacy before putting a patient on a longer term regime?
• How much impact is your program having compared to other marketing investment options available to you?
• What opportunities exist to improve your current sampling program?

Understand answers to these and other key questions with the 2006 Physician Sampling Study. The study will explore:  

• The impact samples and sample supply have on physician prescribing behavior in your therapeutic area
• Alignment of sample supply with physicians’ needs by therapeutic class (depression, hypertension, peptic ulcers, asthma, arthritics, pain management, obesity)
• Effectiveness of sampling in gaining physician access
• Optimal sample delivery mechanisms and which new delivery methodologies are gaining acceptance
• Behaviors with regards to competitor samples being used is assessing efficacy and tolerability
• Points of view with regards to sizes, packaging, stock management, security and quantities needed

Who can benefit from this report?

…Marketing research managers and product managers seeking insights and actionable information to aide planning and program development

…Sales leaders interested in understanding the impact samples have on physician access

…Strategic planners evaluating the value of sampling programs as part of the marketing mix

Special Feature

This report will identify major sample delivery methods including in person delivery, direct mail offerings and online offerings with some tracking showing changes from 2005.

Timing

• The study report is available for purchase

Target Participants

• Approximately 305 General Practitioners / Family Medicine physicians
• Nationally distributed +/- 5.7% margin of error, 19 times out of 20

Cost

• $7,500 excluding taxes. The study presentation PowerPoint deck is available for purchase.

For more information or to order the study, please email
customerservice@mdanalytics.ca or call 1-866-617-0741

________________________________________________________________

* Source:  2005 Insight Syndication Study:  Pharmaceutical Sampling Feb. 2005. N=789